Document Detail

Antepartum testing in patients with hypertensive disorders in pregnancy.
MedLine Citation:
PMID:  18652927     Owner:  NLM     Status:  MEDLINE    
Antepartum fetal testing in pregnant patients with hypertensive disorders may be beneficial in preventing stillbirth and hypoxic sequelae in the fetus. The highest risk patients in this category are those with intrauterine growth restriction, superimposed preeclampsia, associated medical complications such as diabetes, systemic lupus erythematosis, chronic renal disease, or history of a prior stillbirth. The current recommended method of primary testing is a twice weekly modified biophysical profile with either a full BPP or a contraction stress test for backup evaluation of those patients with lack of reactivity or decreased amniotic fluid volume on a modified biophysical profile. Even uncomplicated patients with chronic hypertension or pregnancy-induced hypertension carry an increased risk of perinatal mortality and for these patients testing should begin at 33 to 34 weeks gestation. Patients with complications of intrauterine growth restriction, preeclampsia, diabetes, systemic lupus erythematosis, or chronic renal disease should have antepartum testing begin when intervention for fetal indications is judged to be appropriate, usually beginning at about 26 weeks gestation. Doppler velocimetry may be helpful in further evaluation of those patients in the early third trimester with abnormal primary testing.
Roger K Freeman
Related Documents :
7322327 - Intracranial pressure monitoring in severe pediatric near-drowning.
20479567 - Clinically silent chromaffin-cell tumors: tumor characteristics and long-term prognosis...
18710667 - Resistant hypertension.
3056447 - Challenges in therapy of hypertension in the elderly.
24060587 - The nesfatin 1 level in male patients with manic episode and alterations of nesfatin 1 ...
24528007 - He4 as a serum biomarker for roma prediction and prognosis of epithelial ovarian cancer.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in perinatology     Volume:  32     ISSN:  0146-0005     ISO Abbreviation:  Semin. Perinatol.     Publication Date:  2008 Aug 
Date Detail:
Created Date:  2008-07-25     Completed Date:  2008-12-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7801132     Medline TA:  Semin Perinatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  271-3     Citation Subset:  IM    
University of California at Irvine, Long Beach Memorial Medical Center, and Miller Children's Hospital, Long Beach, CA 90801, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Fetal Diseases / diagnosis*
Fetal Growth Retardation / diagnosis
Heart Rate, Fetal
Pregnancy Complications, Cardiovascular*
Prenatal Diagnosis*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Antenatal testing: diabetes mellitus.
Next Document:  Fetal growth restriction.